Biological Bank for Studies Related to Atrial Fibrillation and Stroke
Biological Bank for Studies Related to Atrial Fibrillation and Stroke
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. This arrhythmia is responsible for 15% of strokes and more than 30% of strokes on people over 65 years.
According to studies, 30 to 40% of isolated atrial fibrillations could be familial. Atrial fibrillation has significant genetic heterogeneity. About 40 genes have been identified as potentially involved. Studies have identified genes common to the risk of atrial fibrillation and stroke. Despite the pathophysiology of atrial fibrillation has been intensively and extensively studied for almost a century, there are still many questions. The pathophysiology is not sufficiently understood to allow finding more effective therapies. It is necessary to identify genetic determinants and thus potentially new pharmacological targets more adapted.
The establishment of a biological database will test hypotheses concerning the genetic origin and thromboembolic process of atrial fibrillation and associated stroke.
Group 1a
Inclusion Criteria :
- AF history
Exclusion Criteria :
Group 1b
Inclusion Criteria :
Exclusion Criteria :
Group 1c
Inclusion Criteria :
Exclusion Criteria :
Group 2
Inclusion Criteria :
Exclusion Criteria :
Group 3
Inclusion Criteria :
Exclusion Criteria :
philippe.chevalier@chu-lyon.fr04 72 35 70 27 ext. +33
elodie.morel01@chu-lyon.fr04 72 35 73 81 ext. +33
Bourg-en-Bresse, 01000, France
fphilippeau@ch-bourg01.fr04.74.45.43.64 ext. +33
Bron, 69677, France
Pierre-Bénite, 69495, France
laura.mechtouff@chu-lyon.fr04 72 35 67 47 ext. +33
lucie.rascle@chu-lyon.fr04 72 35 74 34 ext. +33
philippe.chevalier@chu-lyon.fr04 72 35 70 27 ext. +33
rajae.el-malti@chu-lyon.fr+33 4 72357677 ext. +33
thomas.gilbert@chu-lyon.fr+33478861860 ext. +33
pierre.krolak-salmon@chu-lyon.fr04.72.43.20.50 ext. +33
yves.guilhermet@chu-lyon.fr04.72.43.20.50 ext. +33